No upsets anticipated in EU quality guidance for drug-device combinations (DDC)

The eagerly-awaited draft guidance on quality expectations for EU marketing authorisation applications for integral and other types of drug-device combinations is unlikely to hold any upsets and should be issued the first week in June.

contact us for further information

Posted on 30. Juni 2019
↑ back to top
picture kazurabashi vine bridge

Many bad traps are hidden
in the EU regulatory jungle
We guide you safely

mdi Europa facebook profile mdi Europa linkedin profile

News in Brief

.

grafik CE mark